PRESS RELEASE published on 03/25/2025 at 07:30, 1 year 7 months ago CROSSJECT updates on its collaboration with ETON PHARMACEUTICALS, Inc. and the ZENEO® adrenal insufficiency program CROSSJECT enhances collaboration with ETON PHARMACEUTICALS Inc. on ZENEO adrenal insufficiency program, introducing new hydrocortisone formulation for the hospital market Eton Pharmaceuticals Crossject Hydrocortisone Adrenal Insufficiency ZENEO
BRIEF published on 03/10/2025 at 14:22, 1 year 7 months ago Crossject: Update on voting rights and shares as of January 31, 2025 Share Capital Voting Rights Actions Pharmaceutical Crossject
BRIEF published on 02/12/2025 at 07:35, 1 year 8 months ago Crossject Reappoints Key Members to Executive Board Executive Board Crossject ZEPIZURE® Reappointment Needle-free Technology
PRESS RELEASE published on 02/12/2025 at 07:30, 1 year 8 months ago Crossject announces the reappointment of Patrick Alexandre and Isabelle Liebschutz as members of new, streamlined Executive Board Crossject reappoints Patrick Alexandre and Isabelle Liebschutz to its Executive Board, focusing on final stages of ZEPIZURE registration with the FDA Executive Board Crossject Patrick Alexandre Isabelle Liebschutz ZEPIZURE Registration
BRIEF published on 02/06/2025 at 07:35, 1 year 8 months ago Modification of Convertible Bonds by Crossject Convertible Bonds Funding Crossject ZEPIZURE Heights Capital
PRESS RELEASE published on 02/06/2025 at 07:30, 1 year 8 months ago COMPLETION OF THE TRANSACTIONS ANNOUNCED IN DECEMBER 2024 RELATING TO THE AMENDMENT OF THE CONVERTIBLE BONDS SUBSCRIBED BY AN ENTITY AFFILIATED TO HEIGHTS CAPITAL MANAGEMENT, INC. (“HEIGHTS”) AND THE ISSUE OF A SECOND ASSIMILABLE TRANCHE Crossject completes transactions announced in December 2024 related to amendment of convertible bonds subscribed by an entity affiliated to Heights Capital Management, Inc. Second assimilable tranche issued Convertible Bonds Transaction Bond Issue Crossject Heights Capital Management
BRIEF published on 01/20/2025 at 14:47, 1 year 9 months ago Crossject: Update on voting rights and shares as of December 31, 2024 Share Capital Voting Rights Actions 2024 Crossject
BRIEF published on 12/31/2024 at 10:02, 1 year 10 months ago Crossject: Details on Share Capital and Voting Rights as of November 30, 2024 Share Capital Voting Rights Actions AMF Crossject
BRIEF published on 12/19/2024 at 07:35, 1 year 10 months ago Crossject Advances ZEPIZURE® Supply Chain Readiness Supply Chain U.S. Market ISO 13485 Crossject ZEPIZURE®
PRESS RELEASE published on 12/19/2024 at 07:30, 1 year 10 months ago Crossject confirms ZEPIZURE® supply chain readiness with another successful ISO audit for Quality Management System Crossject confirms readiness of ZEPIZURE® supply chain after successful ISO 13485 audit for manufacturing sites in Dijon and Gray (France), preparing for commercialization in the U.S Supply Chain Commercialization Crossject ZEPIZURE ISO 13485 Audit
Published on 11/03/2026 at 08:00, 11 minutes ago Caledonia Mining Corporation Plc Notice of Q3 2026 Results and Investor Presentation
Published on 11/02/2026 at 23:15, 8 hours 56 minutes ago ATHA Energy Announces Issuance of Common Shares in Satisfaction of US$25 Million Convertible Debenture Interest Payment Obligations
Published on 11/02/2026 at 22:30, 9 hours 41 minutes ago Sparton Files Morrison Mine N-I 43-101 Technical Report
Published on 11/02/2026 at 17:00, 15 hours 11 minutes ago PPX Mining Initiates Operating Permit Process for Igor Processing Plant
Published on 11/03/2026 at 08:05, 6 minutes ago Freedom24 plans Geneva office for Q1 2027, deepening ties with Swiss finance and research
Published on 11/03/2026 at 08:00, 11 minutes ago 2CRSi SA: Binding order of over €60 million1: 2CRSi to deliver 83 NVIDIA HGX B300 AI servers to Exaion by the end of 2026
Published on 11/03/2026 at 08:00, 11 minutes ago V-ZUG expands its international presence in Scandinavia
Published on 11/03/2026 at 07:55, 16 minutes ago Schaeffler announces further performance improvement program
Published on 11/03/2026 at 07:00, 1 hour 11 minutes ago bioMérieux – Third-Quarter 2026 Business Review
Published on 11/02/2026 at 18:30, 13 hours 41 minutes ago Disclosure of transactions in own shares from October 26 to October 30, 2026
Published on 11/02/2026 at 18:17, 13 hours 54 minutes ago Reporting on share buyback transactions carried out between October 28 and October 29, 2026
Published on 11/02/2026 at 18:00, 14 hours 11 minutes ago Covivio - Information on total number of voting rights and share capital